Azulfidine EN-tabs Interactions
There are 269 drugs known to interact with Azulfidine EN-tabs (sulfasalazine), along with 12 disease interactions. Of the total drug interactions, 46 are major, 214 are moderate, and 9 are minor.
- View all 269 medications that may interact with Azulfidine EN-tabs
- View Azulfidine EN-tabs disease interactions (12)
Most frequently checked interactions
View interaction reports for Azulfidine EN-tabs (sulfasalazine) and the medicines listed below.
- amlodipine
- bupropion
- carbidopa / levodopa
- Celebrex (celecoxib)
- chondroitin / glucosamine
- Cimzia (certolizumab)
- Cymbalta (duloxetine)
- diclofenac
- Diovan HCT (hydrochlorothiazide / valsartan)
- Enbrel (etanercept)
- etodolac
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluoxetine
- folic acid
- Humira (adalimumab)
- hydrochlorothiazide
- hydroxychloroquine
- Indocin (indomethacin)
- methotrexate
- Methotrexate LPF Sodium (methotrexate)
- montelukast
- Nexium (esomeprazole)
- pantoprazole
- Plaquenil (hydroxychloroquine)
- pravastatin
- Remicade (infliximab)
- simvastatin
- Synthroid (levothyroxine)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Azulfidine EN-tabs disease interactions
There are 12 disease interactions with Azulfidine EN-tabs (sulfasalazine) which include:
- colitis
- intestinal obstruction
- urinary obstruction
- hematologic toxicity
- hypersensitivity reactions
- liver disease
- porphyria
- renal dysfunction
- renal dysfunction
- folate deficiency
- G6PD deficiency
- crystalluria
More about Azulfidine EN-tabs (sulfasalazine)
- Azulfidine EN-tabs consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: 5-aminosalicylates
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.